Hepatitis C virus non-structural proteins responsible for suppression of the RIG-I/Cardif-induced interferon response
Author(s) -
Megumi Tasaka,
Naoya Sakamoto,
Yoshie Itakura,
Mikagawa,
Yasuhiro Itsui,
Yuko SekineOsajima,
Yuki NishimuraSakurai,
Cheng–Hsin Chen,
Mitsutoshi Yoneyama,
Takashi Fujita,
Takaji Wakita,
Shinya Maekawa,
Nobuyuki Enomoto,
Mamoru Watanabe
Publication year - 2007
Publication title -
journal of general virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.55
H-Index - 167
eISSN - 1465-2099
pISSN - 0022-1317
DOI - 10.1099/vir.0.83056-0
Subject(s) - replicon , biology , interferon , virology , subgenomic mrna , transfection , rig i , viral replication , hepatitis c virus , hek 293 cells , cell culture , ns2 3 protease , virus , microbiology and biotechnology , rna , gene , genetics , plasmid
Viral infections activate cellular expression of type I interferons (IFNs). These responses are partly triggered by RIG-I and mediated by Cardif, TBK1, IKKepsilon and IRF-3. This study analysed the mechanisms of dsRNA-induced IFN responses in various cell lines that supported subgenomic hepatitis C virus (HCV) replication. Transfection of dsRNA into Huh7, HeLa and HEK293 cells induced an IFN expression response as shown by IRF-3 dimerization, whilst these responses were abolished in corresponding cell lines that expressed HCV replicons. Similarly, RIG-I-dependent activation of the IFN-stimulated response element (ISRE) was significantly suppressed by cells expressing the HCV replicon and restored in replicon-eliminated cells. Overexpression analyses of individual HCV non-structural proteins revealed that NS4B, as well as NS34A, significantly inhibited RIG-I-triggered ISRE activation. Taken together, HCV replication and protein expression substantially blocked the dsRNA-triggered, RIG-I-mediated IFN expression response and this blockade was partly mediated by HCV NS4B, as well as NS34A. These mechanisms may contribute to the clinical persistence of HCV infection and could constitute a novel antiviral therapeutic target.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom